Meet Our Team of Experts

David has extensive experience assisting medical device clients with market assessments, opportunity identification, product / franchise expansion strategies, growth strategy development, and new product developments. A recent example included a WW market assessment in the medical diagnostics space where his VOC research and analysis identified key customer requirements and actions the client could take to better compete with existing and new product offerings.

Prior to DeciBio, David worked for six years as a Senior Manager at L.E.K. Consulting where he managed multiple ongoing lifescience engagements at a time. Prior to that, David worked for seven years as a computational biologist at leading organizations, including Genentech and GlaxoSmithKline.

David received his M.B.A. from the Kellogg School of Management at Northwestern University with a focus in international strategy, biotechnology and healthcare and his B.S. in Chemical Engineering from UVA.

Dr. Budel specializes in the analysis of private to mid-cap companies with established to emerging technologies in the life science research tools and molecular diagnostics spaces. He has supported life science research tools and CRO clients facing a broad range of challenging business development issues, including R&D prioritization and evaluation of disruptive technologies. Stephane is a market expert who specializes in the cutting edge of these markets, with a deep understanding of the technical and business potential of innovative technologies such as high content imaging and NGS.

Prior to DeciBio, Stephane spent 2 years as a Life Science Specialist at LEK consulting, where he conducted multiple projects in similar markets.

Interests: Regenerative medicine, microfluidics, emerging tech, platform business models

Interests: Emerging technologies, molecular diagnostics, genomics

Interests: Healthcare and artificial intelligence, clinical NGS, liquid biopsy